Showing results (471-480 of 653) with videos related to
Sort By:
Pageof 66
Scientific Reports|March 17, 2021
Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissueYuki Sunagawa, Suguru Yamada, Fuminori Sonohara, et al.Cancers|November 14, 2023
Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric CancerKoki Nakanishi, Chie Tanaka, Mitsuro Kanda, et al.Cells|July 2, 2021
C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer CellsDaishi Morimoto, Shigeru Matsumura, Itzel Bustos-Villalobos, et al.Digestive Surgery|March 7, 2019
The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution DatasetMasahiro Sasahara, Mitsuro Kanda, Seiji Ito, et al.Journal of Clinical Medicine|December 10, 2021
Intraperitoneal Chemotherapy as Adjuvant or Perioperative Chemotherapy for Patients with Type 4 Scirrhous Gastric Cancer: PHOENIX-GC2 TrialHironori Ishigami, Yasushi Tsuji, Hisashi Shinohara, et al.Cancer Chemotherapy and Pharmacology|March 1, 2014
The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancerGoro Nakayama, Chie Tanaka, Keisuke Uehara, et al.Digestive Surgery|April 29, 2020
Systemic Inflammation Score as a Predictor of Pneumonia after Radical Resection of Gastric Cancer: Analysis of a Multi-Institutional DatasetMichita Shoka, Mitsuro Kanda, Seiji Ito, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 17, 2017
Gastric cancer treated by endoscopic submucosal dissection or endoscopic mucosal resection in Japan from 2004 through 2006: JGCA nationwide registry conducted in 2013Satoshi Tanabe, Shigeki Hirabayashi, Ichiro Oda, et al.World Journal of Surgery|September 26, 2019
Tumor size ≥50 mm as an Independent Prognostic Factor for Patients with Stage II or III Gastric Cancer After Postoperative S-1 Monotherapy: Analysis of a Multi-institution DatasetMasayuki Tsutsuyama, Mitsuro Kanda, Seiji Ito, et al.International Journal of Clinical Oncology|September 23, 2019
Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)Norifumi Hattori, Goro Nakayama, Keisuke Uehara, et al.Pageof 66